NCT04576325
- Conditions
- Aspergillosis, Asthma, Bacterial Infections and Mycoses, +16 more
- Locations
-
- Q-Pharm Pty Ltd (Nucleus Networks) Brisbane, Queensland, Australia
Clinical trial condition
Hypersensitivity
Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.
6,776 public trials
652 recruiting studies
Hypersensitivity trial results
NCT05076084
- Conditions
- Conjunctival Diseases, Conjunctivitis, Conjunctivitis, Allergic, +5 more
- Locations
-
- Hôpital Fondation A. de Rothschuld Paris, France
Completed
Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects
NCT04229303
- Conditions
- Allergic Bronchopulmonary Aspergillosis, Aspergillosis, Aspergillosis, Allergic Bronchopulmonary, +15 more
- Locations
-
- Medicines Evaluation Unit Ltd. (MEU) Manchester, United Kingdom
NCT05118958
- Conditions
- Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
- Locations
-
- KalVista Investigative Site Nottingham, United Kingdom
Completed
Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma
NCT00232999
- Conditions
- Asthma, Bronchial Diseases, Bronchial Hyperreactivity, +7 more
- Locations
-
- Department of Medicine, McMaster University Hamilton, Ontario, Canada
- Centre de cardiology et de pneumologie de l'Universite Laval Sainte-Foy (Quebec City), Quebec, Canada
- University of Saskatchewan Saskatoon, Saskatchewan, Canada
NCT00577655
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Pediatric Care Medical Group, Inc. Huntington Beach, California, United States
- California Allergy & Asthma Medical Group Palmdale, California, United States
- Center for Clinical Trials, LLC Paramount, California, United States
- Integrated Research Group, Inc Riverside, California, United States
NCT02139644
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Teva Investigational Site 12397 Birmingham, Alabama, United States
- Teva Investigational Site 12375 Glendale, Arizona, United States
- Teva Investigational Site 12395 Cypress, California, United States
- Teva Investigational Site 12476 Encinitas, California, United States
NCT02680561
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Teva Investigational Site 13679 Huntington Beach, California, United States
- Teva Investigational Site 13678 Raleigh, North Carolina, United States
- Teva Investigational Site 13677 San Antonio, Texas, United States
Completed
Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils
NCT02452190
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Teva Investigational Site 13212 Birmingham, Alabama, United States
- Teva Investigational Site 13241 Flagstaff, Arizona, United States
- Teva Investigational Site 13194 Glendale, Arkansas, United States
- Teva Investigational Site 13215 Bakersfield, California, United States
NCT02040779
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +7 more
- Locations
-
- Teva Investigational Site 12813 Huntington Beach, California, United States
- Teva Investigational Site 10944 Mission Viejo, California, United States
- Teva Investigational Site 10946 Orange, California, United States
- Teva Investigational Site 10963 Rolling Hills Estates, California, United States